Your search returned 6 results.

Results
	1.	LHRH agonist treatment of breast cancer and gynecological malignancies: a review. [electronic resource] by Burger, C W Prinssen, H M Kenemans, P Producer: 19961108 In: European journal of obstetrics, gynecology, and reproductive biology vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Clostridium septicum myonecrosis and ovarian cancer: a case report and review of literature. [electronic resource] by Prinssen, H M Hoekman, K Burger, C W Producer: 19990222 In: Gynecologic oncology vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The management of borderline epithelial tumors of the ovary. [electronic resource] by Burger, C. W Prinssen, H. M Baak, J. P. A Wagenaar, N Kenemans, P Publication details: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society May 2000 In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: a phase I study. [electronic resource] by Molthoff, C F Prinssen, H M Kenemans, P van Hof, A C den Hollander, W Verheijen, R H Producer: 19980102 In: Cancer vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.p. [electronic resource] by van Zanten-Przybysz, I Molthoff, C F Roos, J C Verheijen, R H van Hof, A Buist, M R Prinssen, H M den Hollander, W Kenemans, P Producer: 20010412 In: International journal of cancer vol. 92 Availability: No items available. Save to lists Add to cart (remove)
	6.	Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01. [electronic resource] by Prinssen, H M Molthoff, C F Verheijen, R H Broadhead, T J Kenemans, P Roos, J C Davies, Q van Hof, A C Frier, M den Hollander, W Wilhelm, A J Baker, T S Sopwith, M Symonds, E M Perkins, A C Producer: 19981016 In: Cancer immunology, immunotherapy : CII vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)